The agency wants comments by Nov. 24 on how robotic surgery makers should test, document and label their systems.
The designation covers newborns and infants under two, a population with no FDA-cleared insulin dosing software.
A $1.29M FDA contract will test whether several language models, supervised by radiologists, can evaluate AI-generated reports across roughly a…
The health research agency has named the teams that will build an autonomous clinical AI agent for patients living with…
Cadence and Limbic are among four products accepted into the FDA's TEMPO pilot for release before authorization.
HHS is standing up two new FDA deputy commissioner posts, with a medtech veteran tipped to oversee AI.
FDA centers lay out a three-stage evidence path for wearable and sensor trial endpoints.
A PLOS Digital Health study finds only three of 1,357 FDA-cleared AI devices were ever tested on patient outcomes.